Patents Assigned to Baxter Healthcare
  • Patent number: 11484469
    Abstract: A reconstitution device includes a body, a first piercing member located at a first end of the body, and a receptacle located at the second end of the body. The receptacle includes a collar configured to engage a vial, and a cap extending from the collar and holding a second piercing member. The second piercing member is disposed within the collar. The reconstitution device includes a first fluid pathway formed within and extending from the first piercing member to the second piercing member. The reconstitution device includes a second fluid pathway formed within and extending from the second piercing member to a portion of the body between the first piercing member and the second piercing member.
    Type: Grant
    Filed: January 22, 2019
    Date of Patent: November 1, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Freddy Desbrosses, Pierpaolo Padula, Marjorie Desriaux, Yannis Abdessalem, Diego Santo-Domingo Porqueras
  • Patent number: 11478566
    Abstract: The present invention provides a hemostatic porous composite sponge comprising: i) a matrix of a biomaterial; and ii) one hydrophilic polymeric component comprising reactive groups wherein i) and ii) are associated with each other so that the reactivity of the polymeric component is retained, wherein associated means that said polymeric component is coated onto a surface of said matrix of a biomaterial, or said matrix is impregnated with said polymeric material, or both.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: October 25, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Hans Christian Hedrich, Joris Hoefinghoff
  • Patent number: 11465099
    Abstract: The present disclosure relates to a water purification apparatus that comprises a reverse osmosis device, RO-device, producing a purified water flow and to a corresponding method. The proposed method comprises detecting at least one fluid property of purified water in the purified water path and regulating a flow rate of water in the recirculation path to fulfill one or more predetermined criteria of the purified water in the purified water path, based on the at least one detected fluid property. The present disclosure also relates to a computer program and a computer program product implementing the method.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: October 11, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Olof Jansson, Peter Sendelius, Henrik Lindgren, Robert Hallström, Carl-Henry Örndal
  • Patent number: 11458232
    Abstract: A medical fluid delivery system including remote machine updating and control is disclosed. An example medical fluid delivery system includes a medical fluid delivery device for a patient. The medical fluid delivery system also includes a server in communication with the medical fluid delivery device and a software application for a mobile device. The software application causes an icon to be displayed representing the medical fluid delivery device. The medical fluid delivery system further includes a first communication link between the medical fluid delivery device and the server, and a second communication link between the server and the software application. The software application receives status updates from the medical fluid delivery device via the server and the first and second links.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: October 4, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventor: Christopher Daniel Gassman
  • Patent number: 11439736
    Abstract: A dialysis system includes a dialysis machine including at least one pump positioned and arranged to pump a dialysis fluid; and a dialysis fluid source located separate from and in fluid communication with the dialysis fluid machine, the dialysis fluid source including a purified water line for carrying purified water, a source of a first concentrate, a source of a second concentrate, a first concentrate pump positioned and arranged to pump first concentrate from the first concentrate source, and a second concentrate pump positioned and arranged to pump second concentrate from the second concentrate source, wherein dialysis fluid is prepared for delivery from the dialysis fluid source to the dialysis machine by mixing the purified water with the first concentrate pumped by the first concentrate pump and the second concentrate pumped by the second concentrate pump.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: September 13, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Justin B. Rohde, Shincy J. Maliekkal
  • Patent number: 11433178
    Abstract: Infusion pump alignment features for vertically-oriented IV tubes are disclosed. In an example, an infusion pump housing includes a tube channel having a radial curvature for bending an IV tube from a horizontal orientation to a vertical orientation when the infusion pump is positioned for operation. The housing also includes a hood having a first side and a second side that are divided by the tube channel. The infusion pump has a door that is connected to the housing for enclosing the tube channel and the hood. The door includes a cavity having dimensions to receive the hood when the door is in a closed position. The hood is configured to engage the cavity to prevent the door from closing if the IV tube is not positioned along the tube channel.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: September 6, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Jiri Slaby, Steve Pippin, Kevin Boron, Robert Cuevas
  • Patent number: 11419967
    Abstract: A renal therapy apparatus includes a blood filter, a blood pump, a treatment fluid pump, and a control unit configured to control at least one of the blood pump or the treatment fluid pump during a filter cleaning sequence. The blood filter includes a plurality of hollow fiber membranes. During the filter cleaning sequence, a fluid mixture is formed by mixing air with a blood-compatible and physiologically safe fluid. Also during the filter cleaning sequence, the fluid mixture is transferred across insides and/or outsides of the plurality of hollow fiber membranes at least one time. The use of the fluid mixture enables the filter cleaning sequence to be performed during the blood treatment.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: August 23, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Justin Rohde, Derek Wiebenson
  • Patent number: 11413385
    Abstract: A dialysis system is disclosed. The example dialysis system includes a housing, a pump actuator housed by the housing, a fluid pumping cassette coupled operably to the housing and including a flexible membrane covering a pump chamber, and a mechanically actuated piston head provided by the pump actuator and positioned to extend towards and away from the fluid pumping cassette. The fluid pumping cassette is positioned such that the flexible membrane of the fluid pumping cassette faces the piston head so that the piston head can push the flexible membrane into the pump chamber of the fluid pumping cassette to expel a fluid from the pump chamber. The example dialysis system also includes a controller programmed to perform a leak test by monitoring a sensed position of the mechanically actuated piston head while the mechanically actuated piston head applies a force to the flexible membrane of the fluid pumping cassette.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: August 16, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventor: Robert W. Childers
  • Patent number: 11406945
    Abstract: A device or system includes a mixer comprising a three-dimensional lattice defining a plurality of tortuous, interconnecting passages therethrough. The mixer is in communication with sources or streams of at least two separate components which, when mixed, form a combined fluid stream. The sources or streams may be, at least initially, on opposite sides of the mixer, or the sources or streams may be on the upstream side of the mixer with an outlet disposed downstream of the mixer. A related method may include providing a mixer comprising a three-dimensional lattice defining a plurality of tortuous, interconnecting passages therethrough, and selecting a material for the mixer based on physical characteristics of said material, said characteristics including a selected one or more of mean flow pore size, thickness and porosity volume.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: August 9, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventor: Yves A. Delmotte
  • Patent number: 11400192
    Abstract: A peritoneal dialysis system is disclosed. An example peritoneal dialysis system includes a water treatment device including a water treatment processor and a first memory and a peritoneal dialysis (“PD”) machine including a PD processor and a second memory. The PD machine is configured to mix water treated by the water treatment device with at least one concentrate to produce a peritoneal dialysis fluid for treatment. The example peritoneal dialysis system also includes a data link between the water treatment processor and the PD processor. The water treatment device is configured to prepare an amount of treated water and, upon communication between the water treatment processor and PD processor over the data link, deliver the amount of the treated water to the PD machine for use in mixing the peritoneal dialysis fluid for the treatment. The treated water has a purity corresponding to an injectable quality or a sterile quality.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: August 2, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventor: Justin B. Rohde
  • Patent number: 11389070
    Abstract: A system for monitoring hemodynamics of a subject is disclosed. The system comprises: a signal generating system configured for providing at least an output electric signal and transmitting the output signal to an organ of the subject. The system also comprises a demodulation system configured for receiving an input electrical signal sensed from the organ responsively to the output electric signal, and for modulating the input signal using the output signal to provide an in-phase component and a quadrature component of the input signal. The system also comprises a processing system configured for monitoring the hemodynamics based on the in-phase and the quadrature components.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: July 19, 2022
    Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SA
    Inventors: Baruch Levy, Eliezer Schusman, Omri Sarfati, Mordechai Dinur
  • Patent number: 11393565
    Abstract: A patient platform for patient engagement and treatment compliance is disclosed. In an example, a home therapy machine of a patient is configured to transmit treatment information and a clinician database is configured to store a medical record and a registration file identifying the home therapy machine and a personal device of the patient as registered devices. The registration file also identifies whether the personal device installed an application for viewing the treatment information. A server is configured to store the treatment information to the medical record, receive an indication that the treatment information is to be displayed at the personal device, and determine from the registration file if the application is installed on the personal device. If the application is not installed, the server converts the treatment information to text message or Short Messaging Service (“SMS”) format for transmission.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: July 19, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Christopher Daniel Gassman, Derek Wiebenson
  • Patent number: 11384748
    Abstract: A blood treatment system includes (i) a blood pump including a first blood pump chamber operable with a first inlet valve and a first outlet valve, and a second blood pump chamber operable with a second inlet valve and a second outlet valve; (ii) an arterial blood line; (iii) a dialyzer placed in fluid communication with the arterial blood line, wherein the blood pump is provided along the arterial blood line upstream of the dialyzer; and (iv) a venous blood line extending downstream from the dialyzer. The system also includes a processor configured to sequence the first and second blood pump chambers so as to achieve a pulsatile pattern of filling the first and second blood pump chambers and an at least substantially constant pattern of discharging blood from the first and second blood pump chambers to the dialyzer.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: July 12, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventor: Troy J. Orr
  • Patent number: 11386994
    Abstract: Therapy device systems, modules, and methods, include memory, one or more processors, in communication with the memory, a plurality of medical therapy devices, a plurality of patient monitoring devices, and a protocol execution module, configured to execute on the one or more processors. The protocol execution module displays a plurality of protocols. The protocol execution module receives a selected protocol, associated with an individual medical therapy device being one of a plurality of medical therapy devices and associated with an individual patient monitoring device being one of a plurality of patient monitoring devices. The protocol execution module executes the selected protocol with the individual medical therapy device.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: July 12, 2022
    Assignees: Baxter International Inc., BAXTER HEALTHCARE SA
    Inventor: Jonathan Alan Handler
  • Patent number: 11383010
    Abstract: The present invention relates to the use of a high-frequency electromagnetic field in method of dialysis where a dialyser is used for the exchange of substances, wherein the blood to be cleaned is exposed to a high-frequency electromagnetic field prior to and/or during contact with the dialyser, and to a dialysis machine for carrying out the use.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: July 12, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Joachim Jankowski, Walter Zidek, Falko Brettschneider, Vera Jankowski
  • Publication number: 20220205902
    Abstract: An analytical method for measuring degradation of iron-carbohydrate complex for intravenous injection may include formulating a reaction solution comprising an iron-carbohydrate complex for intravenous injection, a reducing agent, and a complexing agent. The method may further include measuring absorbance spectral absorbance of an iron-complexing agent species including all or a portion of the complexing agent and iron released from the iron-carbohydrate complex that has been reduced by the reducing agent. Example complexing agents may include 1,10 phenanthroline or ferrozine. An example, iron-carbohydrate complex may be iron sucrose injection.
    Type: Application
    Filed: December 23, 2021
    Publication date: June 30, 2022
    Applicants: Baxter International, Inc., Baxter Healthcare SA
    Inventor: Robert W. Garber, II
  • Patent number: 11357453
    Abstract: The invention provides a neck-worn sensor that is a single, body-worn system that measures the following parameters from an ambulatory patient: heart rate, pulse rate, pulse oximetry, respiratory rate, temperature, thoracic fluid levels, stroke volume, cardiac output, and a parameter sensitive to blood pressure called pulse transit time. From stroke volume, a first algorithm employing a linear model can estimate the patient's pulse pressure. And from pulse pressure and pulse transit time, a second algorithm, also employing a linear algorithm, can estimate systolic blood pressure and diastolic blood pressure. Thus, the sensor can measure all five vital signs along with hemodynamic parameters. It also includes a motion-detecting accelerometer, from which it can determine motion-related parameters such as posture, degree of motion, activity level, respiratory-induced heaving of the chest, and falls.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: June 14, 2022
    Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SA
    Inventors: Matthew Banet, Marshal Singh Dhillon, Susan Meeks Pede, Kenneth Robert Hunt
  • Patent number: 11350918
    Abstract: An assembly for mixing and dispensing a multi-component fluid includes a sheath having first and second fluid chambers, a chamber coupler, and a flexible tip. The chamber coupler forms first and second fluid channels. Additionally, the flexible tip forms a mixing chamber with a variable mixing volume and an outlet. The flexible tip is coupled to the chamber coupler near a distal end of the sheath. In the presence of an activation force, the flexible tip is forced out of the sheath and positioned in a dispensing state with a maximum mixing volume. In the absence of the activation force, the flexible tip is housed within the sheath and positioned in a non-dispensing state with a minimum mixing volume such that the outlet is substantially closed.
    Type: Grant
    Filed: April 18, 2018
    Date of Patent: June 7, 2022
    Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SA
    Inventor: Dustin Christopher Cawthon
  • Patent number: 11343105
    Abstract: The present disclosure relates to a dialysis machine, external medical equipment and to methods for establishing an authenticated connection between a dialysis machine and external medical equipment. The dialysis machine is caused to establish a short-range wireless connection between the dialysis machine and external medical equipment. A first shared key is associated with the short-range wireless connection. The dialysis machine is further configured to obtain a second shared key generated using the first shared key and to generate a first signature, using the obtained second shared key. The dialysis machine is further configured to send, to the external medical equipment, an authentication request comprising the generated first signature and to receive in return an authentication accept comprising a second signature. Furthermore, the dialysis machine is configured to verify the authenticity of the external medical equipment using the second signature.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: May 24, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Olof Ekdahl, Bo Wennberg, Niklas Eklund, Christian Karlsson, Ding Ma
  • Patent number: D963579
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: September 13, 2022
    Assignees: Baxter International Inc., BAXTER HEALTHCARE SA
    Inventors: Baruch Levy, Yochay Kaplan, Eliezer Schusman, Mordechai Dinour